Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation

Background: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess...

Full description

Bibliographic Details
Main Authors: Wei Zheng, Kang-Mei Zhao, Li-Hui Luo, Yang Yu, Sheng-Mei Zhu
Format: Article
Language:English
Published: Wolters Kluwer 2018-01-01
Series:Chinese Medical Journal
Subjects:
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=4;spage=426;epage=434;aulast=Zheng
_version_ 1818534943792300032
author Wei Zheng
Kang-Mei Zhao
Li-Hui Luo
Yang Yu
Sheng-Mei Zhu
author_facet Wei Zheng
Kang-Mei Zhao
Li-Hui Luo
Yang Yu
Sheng-Mei Zhu
author_sort Wei Zheng
collection DOAJ
description Background: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess the effect of blood products on outcomes for LDLT recipients, focusing on apheresis platelets. Methods: This retrospective study included 126 recipients who underwent their first adult-to-adult LDLT. Twenty-four variables including consumption of blood products of 126 LDLT recipients were assessed for their link to short-term outcomes and overall survival. Kaplan-Meier survival curve and the log-rank test were used for recipient survival analysis. A multivariate Cox proportional-hazard model and a propensity score analysis were applied to adjust confounders after potential risk factors were identified by a univariate Cox analysis. Results: Patients who received apheresis platelet transfusion had a lower 90-day cumulative survival (78.9% vs. 94.2%, P = 0.009), but had no significant difference in overall survival in the Cox model, compared with those without apheresis platelet transfusion. Units of apheresis platelet transfusion (hazard ratio [HR] = 3.103, 95% confidence interval [CI]: 1.720–5.600, P < 0.001) and preoperative platelet count (HR = 0.170, 95% CI: 0.040–0.730, P = 0.017) impacted 90-day survival independently. Multivariate Cox regression analysis also found that units of red blood cell (RBC) transfusion (HR = 1.036, 95% CI: 1.006–1.067, P = 0.018), recipient's age (HR = 1.045, 95% CI: 1.005–1.086, P = 0.025), and ABO blood group comparison (HR = 2.990, 95% CI: 1.341–6.669, P = 0.007) were independent risk factors for overall survival after LDLT. Conclusions: This study suggested that apheresis platelets were only associated with early mortality but had no impact on overall survival in LDLT. Units of RBC, recipient's age, and ABO group comparison were independent predictors of long-term outcomes.
first_indexed 2024-12-11T18:18:13Z
format Article
id doaj.art-9e57f9ab3b814c6797e043c21f8400d1
institution Directory Open Access Journal
issn 0366-6999
language English
last_indexed 2024-12-11T18:18:13Z
publishDate 2018-01-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj.art-9e57f9ab3b814c6797e043c21f8400d12022-12-22T00:55:22ZengWolters KluwerChinese Medical Journal0366-69992018-01-01131442643410.4103/0366-6999.225049Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver TransplantationWei ZhengKang-Mei ZhaoLi-Hui LuoYang YuSheng-Mei ZhuBackground: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess the effect of blood products on outcomes for LDLT recipients, focusing on apheresis platelets. Methods: This retrospective study included 126 recipients who underwent their first adult-to-adult LDLT. Twenty-four variables including consumption of blood products of 126 LDLT recipients were assessed for their link to short-term outcomes and overall survival. Kaplan-Meier survival curve and the log-rank test were used for recipient survival analysis. A multivariate Cox proportional-hazard model and a propensity score analysis were applied to adjust confounders after potential risk factors were identified by a univariate Cox analysis. Results: Patients who received apheresis platelet transfusion had a lower 90-day cumulative survival (78.9% vs. 94.2%, P = 0.009), but had no significant difference in overall survival in the Cox model, compared with those without apheresis platelet transfusion. Units of apheresis platelet transfusion (hazard ratio [HR] = 3.103, 95% confidence interval [CI]: 1.720–5.600, P < 0.001) and preoperative platelet count (HR = 0.170, 95% CI: 0.040–0.730, P = 0.017) impacted 90-day survival independently. Multivariate Cox regression analysis also found that units of red blood cell (RBC) transfusion (HR = 1.036, 95% CI: 1.006–1.067, P = 0.018), recipient's age (HR = 1.045, 95% CI: 1.005–1.086, P = 0.025), and ABO blood group comparison (HR = 2.990, 95% CI: 1.341–6.669, P = 0.007) were independent risk factors for overall survival after LDLT. Conclusions: This study suggested that apheresis platelets were only associated with early mortality but had no impact on overall survival in LDLT. Units of RBC, recipient's age, and ABO group comparison were independent predictors of long-term outcomes.http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=4;spage=426;epage=434;aulast=ZhengApheresis Platelets; Blood Transfusion; Living Donor Liver Transplantation; Outcome; Red Blood Cell
spellingShingle Wei Zheng
Kang-Mei Zhao
Li-Hui Luo
Yang Yu
Sheng-Mei Zhu
Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
Chinese Medical Journal
Apheresis Platelets; Blood Transfusion; Living Donor Liver Transplantation; Outcome; Red Blood Cell
title Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_full Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_fullStr Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_full_unstemmed Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_short Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation
title_sort perioperative single donor platelet apheresis and red blood cell transfusion impact on 90 day and overall survival in living donor liver transplantation
topic Apheresis Platelets; Blood Transfusion; Living Donor Liver Transplantation; Outcome; Red Blood Cell
url http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=4;spage=426;epage=434;aulast=Zheng
work_keys_str_mv AT weizheng perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation
AT kangmeizhao perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation
AT lihuiluo perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation
AT yangyu perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation
AT shengmeizhu perioperativesingledonorplateletapheresisandredbloodcelltransfusionimpacton90dayandoverallsurvivalinlivingdonorlivertransplantation